Yun Zhong
Stock Analyst at Wedbush
(0.05)
# 4,788
Out of 5,078 analysts
457
Total ratings
35.5%
Success rate
-11.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yun Zhong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutics | Reiterated: Buy | $34 | $11.85 | +186.92% | 24 | Oct 22, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $28 | $9.58 | +192.28% | 14 | Oct 22, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $13 | $3.47 | +274.64% | 13 | Oct 19, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Buy | $35 | $17.73 | +97.41% | 34 | Oct 16, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $15 | $2.29 | +555.02% | 25 | Oct 7, 2026 | |
| BNTC Benitec Biopharma | Reiterated: Buy | $17 | $8.65 | +96.53% | 3 | Oct 5, 2026 | |
| RZLT Rezolute | Reiterated: Buy | $6 | $3.86 | +55.64% | 26 | Oct 5, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $12 | $3.18 | +277.36% | 23 | Sep 30, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $8 | $3.30 | +142.42% | 10 | Sep 29, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $327 | $243.37 | +34.36% | 33 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $173 | $138.43 | +24.97% | 30 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 | $55.95 | +68.01% | 18 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 | $1.87 | +809.09% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.74 | +359.77% | 25 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.19 | +150.78% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $11.28 | +41.84% | 16 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 | $3.37 | +137.39% | 24 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $1.33 | n/a | 15 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.96 | n/a | 14 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 | $22.43 | n/a | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $20.07 | n/a | 13 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.16 | n/a | 7 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.2817 | n/a | 9 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $6.18 | n/a | 13 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $76.78 | n/a | 9 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.9601 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $12.80 | n/a | 2 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $18.41 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.47 | n/a | 3 | Jun 28, 2018 |
MoonLake Immunotherapeutics
Oct 22, 2026
Reiterated: Buy
Price Target: $34
Current: $11.85
Upside: +186.92%
Sagimet Biosciences
Oct 22, 2026
Reiterated: Buy
Price Target: $28
Current: $9.58
Upside: +192.28%
Opus Genetics
Oct 19, 2026
Reiterated: Buy
Price Target: $13
Current: $3.47
Upside: +274.64%
Sarepta Therapeutics
Oct 16, 2026
Reiterated: Buy
Price Target: $35
Current: $17.73
Upside: +97.41%
Rocket Pharmaceuticals
Oct 7, 2026
Reiterated: Buy
Price Target: $15
Current: $2.29
Upside: +555.02%
Benitec Biopharma
Oct 5, 2026
Reiterated: Buy
Price Target: $17
Current: $8.65
Upside: +96.53%
Rezolute
Oct 5, 2026
Reiterated: Buy
Price Target: $6
Current: $3.86
Upside: +55.64%
Wave Life Sciences
Sep 30, 2026
Reiterated: Buy
Price Target: $12
Current: $3.18
Upside: +277.36%
Camp4 Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $8
Current: $3.30
Upside: +142.42%
Ascendis Pharma
Sep 16, 2026
Reiterated: Buy
Price Target: $327
Current: $243.37
Upside: +34.36%
Aug 31, 2026
Reiterated: Buy
Price Target: $173
Current: $138.43
Upside: +24.97%
Aug 18, 2026
Reiterated: Buy
Price Target: $94
Current: $55.95
Upside: +68.01%
Aug 11, 2026
Rated: Buy
Price Target: $17
Current: $1.87
Upside: +809.09%
Aug 7, 2026
Reiterated: Buy
Price Target: $8
Current: $1.74
Upside: +359.77%
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $3.19
Upside: +150.78%
Aug 4, 2026
Reiterated: Hold
Price Target: $16
Current: $11.28
Upside: +41.84%
Apr 21, 2026
Downgraded: Hold
Price Target: $8
Current: $3.37
Upside: +137.39%
Mar 30, 2023
Rated: Buy
Price Target: $28
Current: $1.33
Upside: n/a
Mar 30, 2023
Reiterated: Hold
Price Target: n/a
Current: $3.96
Upside: n/a
Mar 28, 2023
Rated: Buy
Price Target: $38
Current: $22.43
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $4
Current: $20.07
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $3.16
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $4
Current: $0.2817
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $8
Current: $6.18
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $76.78
Upside: n/a
May 12, 2020
Reiterated: Buy
Price Target: $10
Current: $0.9601
Upside: n/a
Feb 4, 2020
Reiterated: Buy
Price Target: $14
Current: $12.80
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $18.41
Upside: n/a
Jun 28, 2018
Downgraded: Hold
Price Target: n/a
Current: $15.47
Upside: n/a